GlassScriptPhysician profile
Bertram A Lewis
NPI 1124096060
$8,842.97
in general payments reported to CMS, 2019-2025
38 companies · $2,991 in 2025
The $2,991 reported for 2025 was more than what 86% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $365 · 2020: $235 · 2021: $617 · 2022: $689 · 2023: $1,481 · 2024: $2,466 · 2025: $2,991.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,550 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $2,040 · Travel and Lodging: $1,347.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,549.87 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $2,040.00 |
| Travel and Lodging | $1,347.21 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $2,654.75 | 2021-2025 | Interstim |
| Boston Scientific Corporation | $1,717.91 | 2019-2024 | |
| Teleflex LLC | $666.20 | 2021-2025 | Urolift, Barrigel |
| Coloplast Corp | $625.81 | 2019-2025 | Titan |
| Astellas Pharma US INC | $429.75 | 2019-2024 | Xtandi, Myrbetriq |
| Procept Biorobotics Corporation | $284.38 | 2021-2025 | |
| Myriad Genetic Laboratories, INC. | $213.50 | 2022-2024 | Precisetumor, Prolaris |
| Endo Pharmaceuticals INC. | $208.33 | 2020-2023 | Xiaflex, Aveed, Edex |
| Janssen Biotech, INC. | $206.73 | 2019-2023 | Erleada |
| Baxter Healthcare | $187.66 | 2024-2025 | Tisseel, Perclot |
| Endo USA, INC. | $181.90 | 2024-2025 | Xiaflex, Aveed |
| Axonics, INC. | $173.53 | 2021-2024 | Axonics, Bulkamid |
| Laborie Medical Technologies Corp. | $152.30 | 2023 | |
| Abbvie INC. | $149.11 | 2019-2025 | |
| Travere Therapeutics, INC. | $137.42 | 2019-2022 |
Show all 38 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sumitomo Pharma America, INC. | $118.06 | 2023-2024 | Gemtesa, Orgovyx |
| Merck Sharp & Dohme LLC | $81.92 | 2022-2025 | Bridion |
| Olympus America INC. | $63.35 | 2024 | Itind System |
| Pfizer INC. | $62.45 | 2019-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $56.89 | 2022 | |
| Urovant Sciences INC | $55.20 | 2021-2022 | |
| Neotract INC. | $48.46 | 2019-2020 | |
| 180 Medical, INC. | $46.77 | 2021-2025 | |
| Medtronic USA, INC. | $38.69 | 2020 | |
| Astrazeneca Pharmaceuticals LP | $31.91 | 2020-2023 | Lynparza |
| Novartis Pharmaceuticals Corporation | $31.57 | 2025 | |
| Urogen Pharma, INC. | $25.35 | 2023 | Jelmyto |
| Calyxo, INC. | $23.90 | 2025 | Cvac Aspiration System |
| Tolmar, INC. | $23.69 | 2023 | |
| Coastal Medical Technologies LLC | $21.86 | 2024 | |
| Ethicon US, LLC | $20.35 | 2024 | Stratafix, Ethicon, Echelon Endopath |
| Civco Medical Instruments | $19.00 | 2024 | |
| Ambu INC. | $18.99 | 2021 | |
| Myovant Sciences INC. | $18.88 | 2022 | |
| Antares Pharma, INC. | $13.80 | 2024 | Xyosted |
| Allergan, INC. | $12.09 | 2020 | |
| Janssen Pharmaceuticals, INC | $11.60 | 2019 | |
| Ets Wound Care LLC | $8.91 | 2024 | Mirragen Advanced Wound Matrix |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bertram Lewis listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.